10/25/2012
Good news! The Wall Street Journal awarded Kalydeco the 2012 Technology Innovation Award in the Medicine and Biotech category. The awards recognize technological breakthroughs that are “game-changers” or have a wide impact in their field and beyond.
The Wall Street Journal has just awarded Kalydeco, the first drug to address the underlying cause of cystic fibrosis, the 2012 Technology Innovation Award in the Medicine and Biotech category.